What Is TMAO? Gut Bacteria, Diet, and Heart Disease Risk

Trimethylamine N-oxide, commonly known as TMAO, is a small molecule produced by your gut bacteria and liver when you eat certain foods—especially those rich in choline, L-carnitine, and betaine. Once considered a biological curiosity, TMAO has become one of the most researched metabolites in cardiovascular science because of its association with heart disease, stroke, and metabolic conditions. Understanding what TMAO is, how your body makes it, and what the science actually says can help you make more informed choices about your diet, gut health, and long-term cardiovascular wellbeing. This guide breaks down the biology, the evidence, the limitations, and the practical strategies supported by current research.

What Is TMAO?

TMAO, or trimethylamine N-oxide, is a metabolite—a substance produced during metabolism. It is not a nutrient you consume directly in meaningful amounts, nor is it a vitamin or mineral. Instead, TMAO is what biochemists call a downstream metabolite: a compound your body generates through a multi-step biological process involving the foods you eat, the bacteria that live in your gut, and enzymes in your liver.

The name can be confusing because two related molecules are involved. Trimethylamine (TMA) is a gas with a distinct fishy odour. TMA is produced when gut bacteria break down dietary precursors such as choline, L-carnitine, and betaine. TMA then enters the bloodstream and travels to the liver, where an enzyme called flavin-containing monooxygenase 3 (FMO3) converts it into TMAO. TMAO is chemically stable, circulates in your blood, and is eventually excreted through urine and, to a lesser extent, bile.

For decades, TMAO was studied mainly in the context of fish spoilage and marine biology—fish naturally accumulate TMAO in their tissues, which is why seafood contains it. The scientific landscape changed dramatically around 2011, when researchers at the Cleveland Clinic, led by Dr. Stanley Hazen, published landmark findings linking elevated circulating TMAO to increased cardiovascular risk. Since then, hundreds of studies have explored the relationship between TMAO, diet, gut microbiome composition, and heart health.

It is important to establish what TMAO is not. It is not a toxin in the traditional sense, and it is not inherently harmful. It is a naturally occurring metabolite that every human body produces. The question that concerns scientists is not whether TMAO exists, but whether chronically elevated levels—often driven by particular dietary patterns and gut bacterial profiles—may contribute to or signal heightened cardiovascular risk.

Researchers also distinguish between TMAO measured in the blood as a biomarker and TMAO as a causal factor. These are different scientific claims with different levels of supporting evidence. Much of the current debate centres on whether TMAO actively contributes to disease processes or simply reflects them. We will explore this distinction carefully throughout this article.

How Your Gut Bacteria Produce TMAO

The production of TMAO is a striking example of how intimately human physiology is intertwined with the trillions of microorganisms that inhabit the gastrointestinal tract. Without gut bacteria capable of producing specific enzymes, the TMAO pathway cannot operate efficiently. This is why two people can eat the same meal and have very different resulting TMAO levels.

Step 1: Dietary Precursors Enter the Gut

The TMAO pathway begins with foods containing precursors—compounds that can be converted into trimethylamine by gut bacteria. The three most important dietary precursors are:

Discover the Microbiome Test

ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure data

Microbiome Test Kit

• Choline, found in high concentrations in eggs, liver, red meat, poultry, fish, and dairy, as well as in smaller amounts in many plant foods
• L-carnitine, abundant in red meat (especially beef and lamb) and to a lesser extent in dairy and chicken
• Betaine, found in wheat, spinach, beets, and shellfish
• Phosphatidylcholine, a phospholipid form of choline present in eggs, soy, and organ meats

When you eat these foods, the precursors travel to the large intestine, where they encounter a diverse community of bacteria. Most of the absorption of these compounds actually occurs in the small intestine. A portion, however, reaches the colon, where bacteria can act on them.

Step 2: Gut Bacteria Convert Precursors into TMA

Specific gut bacteria possess enzymes that can cleave choline or L-carnitine, releasing trimethylamine (TMA). The most well-characterised of these is the cutC gene, which encodes a choline trimethylamine-lyase enzyme. Bacteria carrying the cutC gene—primarily certain species within the Firmicutes phylum, including some Clostridium and Escherichia species—are major TMA producers. Similarly, the cntA gene is associated with carnitine conversion to TMA.

This is where the concept of "meat-eating bacteria" versus "plant-eating bacteria" becomes relevant. Research has shown that individuals who habitually consume a diet high in animal products tend to harbour gut bacterial communities more efficient at converting carnitine and choline into TMA. When these same individuals are given a steak or a carnitine supplement, their TMAO levels rise significantly. By contrast, people who follow a vegan or vegetarian diet for an extended period often show much lower TMAO production after consuming the same carnitine dose. Their microbiomes have adapted—not necessarily because they lack the relevant bacteria entirely, but because the abundance and activity of TMA-producing species are lower.

This finding is important because it demonstrates that TMAO production is not fixed. It is dynamic and modifiable. The composition and metabolic capacity of your gut microbiome influence how much TMA your body generates from a given meal. You can read more about how the microbiome shapes metabolism and health through resources on understanding your gut microbiome.

Step 3: The Liver Converts TMA to TMAO

Once TMA is produced in the gut, it is absorbed into the portal circulation and transported to the liver. There, the enzyme FMO3 (flavin-containing monooxygenase 3) oxidises TMA into TMAO. FMO3 is the primary enzyme responsible for this conversion in humans, and variations in FMO3 activity—due to genetics, liver health, or other factors—can influence how much TMAO circulates in the blood.

FMO3 is also the enzyme implicated in a rare genetic condition called trimethylaminuria, or "fish odour syndrome," in which FMO3 function is impaired. People with this condition cannot efficiently convert TMA to TMAO, leading to TMA accumulation and a characteristic body odour. This illustrates the critical role FMO3 plays in the TMAO pathway.

Step 4: TMAO Circulates and Is Excreted

TMAO then enters the systemic bloodstream, where it can be measured. It is eventually cleared by the kidneys and excreted in urine. This renal clearance pathway explains why people with chronic kidney disease often have elevated TMAO levels—their kidneys are less efficient at removing it from circulation.

The complete TMAO pathway—diet → gut bacteria → TMA → liver FMO3 → TMAO in blood → kidney excretion—illustrates why TMAO is sometimes described as a "meta-organismal" metabolite. Its production depends on the coordinated activity of your diet, your gut microbiome, your liver, and your kidneys.

View example recommendations from the InnerBuddies platform

Preview the nutrition, supplement, food diary and food recipe platform recommendations that InnerBuddies can generate based on your gut microbiome test

View example recommendations

What Foods Raise TMAO Levels?

Because TMAO is produced from dietary precursors, the foods you eat directly influence your TMAO levels. However, the relationship is not as simple as "food X raises TMAO, food Y lowers it." Individual variation in the microbiome means that the same food can produce different TMAO responses in different people.

Red Meat

Red meat, particularly beef and lamb, is one of the most potent dietary TMAO sources because it is rich in both L-carnitine and choline. Studies have consistently shown that consuming red meat increases circulating TMAO in omnivores, often within hours of ingestion. Interestingly, the increase appears more pronounced in habitual meat-eaters than in vegetarians, reflecting microbiome adaptation. Processed red meats, such as sausages and bacon, may also carry additional cardiovascular risks due to their sodium and preservative content.

Eggs and Dietary Choline

Eggs are an exceptionally concentrated source of choline—particularly in the yolk—and phosphatidylcholine. Some studies show that egg consumption can raise TMAO levels, especially in individuals whose gut microbiomes harbour high levels of choline-converting bacteria. However, the picture is nuanced. Eggs also provide high-quality protein, essential vitamins, and bioactive compounds. Many nutrition authorities continue to consider moderate egg consumption appropriate within a heart-healthy dietary pattern for most people. The cholesterol and choline content should be considered in context rather than in isolation.

Fish and Seafood

Seafood is unique in the TMAO story. Fish, especially cold-water marine fish, are naturally rich in TMAO—it helps them regulate osmotic balance in seawater. Eating fish can therefore raise circulating TMAO directly, without requiring gut bacterial conversion. This creates what appears to be a paradox: fish consumption raises TMAO, yet fish is consistently associated with cardiovascular benefit in observational studies and clinical trials.

Several explanations have been proposed. First, the TMAO from fish may be absorbed and excreted differently than TMAO produced endogenously from gut bacterial conversion. Second, fish contains omega-3 fatty acids, selenium, vitamin D, and high-quality protein—all of which confer cardiovascular protection. Third, the overall dietary context matters; fish is typically consumed as part of Mediterranean or other plant-forward dietary patterns that are associated with lower cardiovascular risk. This fish paradox highlights an essential principle: a single biomarker cannot capture the full complexity of the diet–disease relationship.

Dairy Products

Dairy foods contain choline and, in some forms, carnitine, though typically in lower concentrations than red meat. Milk, cheese, and yogurt can contribute to TMAO precursor intake, but the effect on circulating TMAO appears modest in most studies. Fermented dairy products such as yogurt may have additional effects on the gut microbiome that could theoretically influence TMAO production, but this remains an area of active research.

Plant Foods and Betaine

Some plant foods, notably spinach, beets, and wheat, are rich in betaine, which can also be converted to TMA by gut bacteria. However, the overall TMAO response to plant foods is generally lower than to animal products, and plant foods contain fibre, polyphenols, and other compounds that support a more diverse microbiome. This may explain why plant-based dietary patterns are associated with lower TMAO levels overall, despite containing some TMAO precursors.

A Practical Meal Breakdown

The following table summarises the main dietary sources of TMAO precursors and their typical relative impact on circulating TMAO levels in habitual omnivores:

Food Category	Key Precursor(s)	Relative Impact on TMAO	Contextual Notes
Red meat (beef, lamb)	L-carnitine, choline	High	Largest sustained increases in habitual omnivores
Eggs	Choline, phosphatidylcholine	Moderate to high	Variable between individuals; nutritional benefits
Fish and shellfish	Preformed TMAO, choline	Moderate to high (direct)	Associated with cardiovascular benefit despite TMAO
Poultry	Choline, some carnitine	Moderate	Lower than red meat
Dairy	Choline, low carnitine	Low to moderate	Effect modest in most studies
Plant foods (spinach, beets, wheat)	Betaine	Low	Fibre and polyphenols support microbiome diversity

This table should be interpreted as a general guide, not a personal prescription. Your individual TMAO response depends on your microbiome composition, liver FMO3 activity, kidney function, and overall dietary pattern.

What Does Science Say About TMAO and Heart Disease?

The relationship between TMAO and cardiovascular disease is one of the most actively debated areas in nutrition science. The evidence base includes large observational studies, mechanistic animal research, and a smaller number of human intervention trials. Each type of evidence has strengths and limitations that must be understood to interpret the findings responsibly.

Observational Evidence: Associations with Cardiovascular Events

Since the Cleveland Clinic's landmark 2011 study, multiple large-scale human cohorts have reported associations between elevated plasma TMAO and adverse cardiovascular outcomes. These include:

• Major adverse cardiovascular events (MACE) in patients undergoing cardiac evaluation
• Increased risk of heart attack, stroke, and peripheral artery disease
• Higher mortality in patients with heart failure
• Increased risk of incident cardiovascular events in apparently healthy populations

A 2017 meta-analysis pooling data from several prospective studies found that higher TMAO levels were associated with a significantly increased risk of major adverse cardiovascular events, with an approximately 60–70% higher relative risk in the highest versus lowest TMAO categories after adjustment for traditional risk factors. This is a substantial association, but it is still an association.

Mechanistic Evidence: How TMAO Might Contribute to Disease

Animal and laboratory studies have revealed several plausible biological mechanisms through which TMAO could influence cardiovascular health:

• Enhanced platelet reactivity: TMAO enhances platelet activation and aggregation, potentially increasing the risk of blood clot formation. This has been demonstrated in human platelet studies and animal models.
• Vascular inflammation: TMAO activates inflammatory pathways in endothelial cells and vascular smooth muscle, including activation of nuclear factor kappa B (NF-κB) signalling.
• Atherosclerosis promotion: In mice, TMAO has been shown to accelerate the development of atherosclerotic plaques, partly by altering cholesterol metabolism and bile acid pathways.
• Endothelial dysfunction: TMAO may impair nitric oxide bioavailability, which is essential for healthy blood vessel function.
• Cardiac fibrosis: Some animal studies suggest TMAO contributes to cardiac fibrosis and adverse cardiac remodelling.

These mechanisms are biologically plausible and provide a rationale for the observed associations. However, it is crucial to recognise that most of this mechanistic evidence comes from animal models, often using TMAO doses or concentrations that may not reflect typical human physiology. Human mechanistic studies are fewer and often use biomarkers rather than clinical endpoints.

Intervention Evidence: Feeding Studies and Dietary Trials

Human dietary intervention studies have provided important insights. Studies from the Cleveland Clinic and other groups have shown that:

• Consuming red meat increases TMAO production in omnivores
• The same dietary challenge produces much lower TMAO responses in vegetarians and vegans
• Dietary patterns rich in plant foods are associated with lower TMAO levels
• Short-term increases in dietary carnitine or choline raise TMAO in a dose-dependent manner

What has not yet been demonstrated in large, long-term randomised controlled trials is whether specifically lowering TMAO levels translates into reduced cardiovascular events. This is the critical evidence gap. Establishing a biomarker–disease association is not the same as proving that modifying the biomarker reduces disease risk.

2-minute self-check Is a gut microbiome test useful for you? Answer a few quick questions and find out if a microbiome test is actually useful for you. ✔ Takes 2 minutes ✔ Based on your symptoms & lifestyle ✔ Clear yes/no recommendation Check if a test is right for me →

The Scientific Debate: Correlation Versus Causation

The TMAO field is characterised by scientific disagreement, and this is a sign of healthy scientific discourse rather than confusion. Some researchers, including Dr. Hazen's group, argue that the cumulative evidence supports TMAO as a causal contributor to cardiovascular disease, making it an attractive therapeutic target. Others are more cautious, noting that TMAO may simply be a marker of animal product intake, impaired kidney function, or other lifestyle factors that themselves drive cardiovascular risk.

The confusion data and associations complicate the picture further. Some studies have found that TMAO is associated with worse outcomes even after extensive adjustment for dietary habits and kidney function, suggesting an independent effect. Others have reported weaker associations—or even null findings—in different populations or after controlling for different confounders. The heterogeneity of study designs, populations, and TMAO measurement methods makes drawing firm conclusions challenging.

There is also the intriguing question of whether TMAO itself could have beneficial physiological functions. TMAO acts as an osmolyte, helping protect cells from osmotic stress. It has been shown to stabilise protein folding and may have protective effects in certain tissues. This does not negate the cardiovascular concerns, but it reminds us that biological molecules are rarely purely "good" or "bad."

Landmark Research and Key Studies

The Cleveland Clinic has been the epicentre of TMAO research. Key publications include:

• A 2011 Nature paper linking dietary choline, gut microbiota, and TMAO to cardiovascular risk
• A 2013 Nature Medicine paper showing that carnitine from red meat is converted by gut bacteria to TMAO and accelerates atherosclerosis in mice
• Multiple prospective studies in Cell, European Heart Journal, and Journal of the American College of Cardiology demonstrating associations between TMAO and cardiovascular events
• Studies identifying DMB (3,3-dimethyl-1-butanol), a compound found in olive oil and balsamic vinegar, as a potential inhibitor of TMA production

These studies collectively form a substantial body of evidence that is more than a single observation but less than definitive proof of causation. The most scientifically responsible position is to acknowledge the association while remaining honest about its limitations.

For readers who want to explore how their own gut microbiome may influence how their body metabolises different foods, a gut microbiome test can provide personalised insight. Test results should be interpreted as educational information, however, not as a clinical diagnostic tool for cardiovascular risk.

How to Lower TMAO: Evidence-Based Strategies

Because TMAO is associated with cardiovascular risk—and because some of its production depends on modifiable factors—many people are interested in lowering their TMAO levels. Several strategies have scientific support, though it is important to remember that the ultimate goal is cardiovascular health, not simply achieving a lower TMAO number on a lab report.

Adopt a Plant-Forward Dietary Pattern

The single most consistently supported strategy for lowering TMAO is shifting toward a plant-centric diet. This does not necessarily mean becoming vegan or vegetarian. It means making plant foods the foundation of your meals while being selective and moderate with animal products.

The Mediterranean diet is an excellent template. It emphasises vegetables, fruits, legumes, whole grains, nuts, seeds, olive oil, and fish, with limited red meat, processed foods, and refined carbohydrates. Observational studies consistently link Mediterranean-style eating with lower cardiovascular risk, and some studies show lower TMAO levels in Mediterranean diet adherents. The diet also supports a diverse gut microbiome through its fibre and polyphenol content.

A plant-based or vegan diet produces the most pronounced reductions in TMAO production capacity. Studies have shown that switching from an omnivorous to a vegetarian or vegan diet reduces the abundance of TMA-producing bacteria in the gut, meaning that even when carnitine or choline is consumed, less TMA is generated. This adaptation appears to occur within weeks to months.

Reduce Red Meat Consumption

Because red meat is the richest source of both L-carnitine and choline, reducing its intake is one of the most direct ways to lower TMAO production. This does not mean red meat must be eliminated. Many nutrition authorities recommend limiting red meat to occasional consumption—for example, once per week—and choosing leaner cuts. The cardiovascular benefits of reducing red meat extend beyond TMAO to include lower saturated fat intake, reduced sodium, and less heme iron, which is also linked to cardiovascular risk.

Increase Fibre and Prebiotic Intake

Fibre is not a direct inhibitor of TMA production, but it is one of the most important nutrients for cultivating a healthy, diverse gut microbiome. A diet rich in diverse fibre sources—vegetables, fruits, legumes, whole grains, nuts, and seeds—supports the growth of beneficial bacteria that compete with TMA-producing species for resources and produce short-chain fatty acids such as butyrate that help maintain gut barrier integrity and reduce inflammation.

Prebiotics are specific types of fibre that selectively feed beneficial bacteria. Foods rich in prebiotics include garlic, onions, leeks, asparagus, bananas, oats, and legumes. Aiming for a wide variety of plant foods—some nutrition scientists recommend 30 or more different plant foods per week—encourages microbiome diversity, which is generally associated with better metabolic and cardiovascular health.

Consider DMB-Rich Foods

One of the more exciting developments in TMAO research is the identification of natural compounds that can inhibit TMA production. DMB (3,3-dimethyl-1-butanol) is found in relatively high concentrations in extra virgin olive oil and some balsamic vinegars. Studies in mice have shown that DMB inhibits the microbial enzyme responsible for TMA formation, reducing TMAO levels and attenuating atherosclerosis. Human studies are limited but promising, and olive oil is already a cornerstone of heart-healthy Mediterranean eating.

Exercise Regularly

Physical activity has broad cardiovascular benefits and may influence TMAO levels indirectly through effects on the gut microbiome, metabolism, and kidney function. Regular aerobic exercise is associated with a more diverse microbiome and improved metabolic health, both of which can reduce TMAO production. While the specific effect of exercise on TMAO is not the primary mechanism of its cardiovascular protection, it is a valuable component of any heart-healthy lifestyle.

Be Cautious with Probiotic Supplements

Many people assume that probiotic supplements will automatically improve gut health and lower TMAO. The evidence for this is weak. Some probiotics may transiently alter gut bacterial populations, but they rarely colonise the gut permanently, and their effects on TMAO production are inconsistent. In fact, some probiotic strains could theoretically increase TMA production depending on their enzymatic capabilities. A food-first approach to gut health—using fermented foods, fibre-rich plants, and diverse whole foods—is generally preferable to relying on supplements, unless a specific clinical indication exists.

Become a member of the InnerBuddies community

Perform a gut microbiome test every couple of months and view your progress while following-up on our recommendations

Take an InnerBuddies membership

That said, some preliminary research suggests certain probiotic strains or synbiotic combinations could be helpful in specific contexts. Anyone considering probiotics for cardiovascular or metabolic health should discuss this with a healthcare provider who can consider individual needs and the strength of available evidence.

Support Kidney Health

Because TMAO is cleared by the kidneys, kidney function matters for TMAO levels. Maintaining healthy blood pressure, staying well hydrated, avoiding excessive salt and protein intake, and managing conditions like diabetes are important for kidney health. For people with chronic kidney disease, elevated TMAO is common and may contribute to cardiovascular risk, but TMAO-lowering strategies should be developed in consultation with a nephrologist.

What About Eggs and Fish?

Many people are confused about how to handle eggs and fish—two foods that raise TMAO but also provide important nutrients. The most balanced approach is to consider overall dietary context:

• Eggs: For most people, moderate egg consumption (typically up to one per day for healthy adults) is considered acceptable within a heart-healthy diet. If you have high TMAO and are concerned about cardiovascular risk, discuss egg intake with your healthcare provider. The choline in eggs is also important for brain and liver health.
• Fish: Because fish consumption is consistently associated with cardiovascular benefit, most experts recommend eating fish 1–2 times per week, especially fatty fish rich in omega-3s. The TMAO from fish does not appear to outweigh its cardiovascular benefits in observational research.

A Practical Summary of TMAO-Lowering Strategies

1. Make plant foods the foundation of your diet—aim for a wide variety of vegetables, fruits, legumes, whole grains, nuts, and seeds.
2. Reduce red meat to occasional consumption; favour fish, poultry, or plant proteins.
3. Use extra virgin olive oil as your primary fat and include fibre-rich foods at each meal.
4. Avoid excessive carnitine or choline supplements unless medically indicated.
5. Exercise regularly, maintain a healthy weight, and manage blood pressure and blood sugar.
6. Consider the total dietary pattern rather than single nutrients; extreme restriction is rarely necessary or helpful.

These strategies support both lower TMAO levels and better overall cardiovascular health. If you are curious about your own gut microbiome composition and how it might influence how your body processes dietary precursors, a personalized microbiome analysis may offer useful educational context.

TMAO and Other Health Conditions

While cardiovascular disease has dominated TMAO research, elevated TMAO levels have also been associated with several other health conditions. These findings expand our understanding of TMAO's broader metabolic significance but should be interpreted with the same nuance and caution as cardiovascular associations.

Chronic Kidney Disease

Because TMAO is cleared by the kidneys, people with chronic kidney disease (CKD) often have markedly elevated TMAO levels. Studies in CKD populations have linked elevated TMAO to increased cardiovascular events and mortality—a particularly significant finding because cardiovascular disease is the leading cause of death in people with kidney disease. Some research suggests that TMAO may also contribute to kidney fibrosis and disease progression, although this remains speculative and based largely on animal models. The relationship between TMAO and kidney disease is partly a matter of reduced clearance and partly a matter of altered gut microbiome composition, which is common in CKD.

Type 2 Diabetes and Insulin Resistance

Several studies have reported associations between higher TMAO levels and insulin resistance, type 2 diabetes, and metabolic syndrome. The direction of the relationship is not fully established. Some research suggests that TMAO may influence glucose metabolism and adipose tissue inflammation, while other studies suggest that metabolic dysfunction alters the gut microbiome in ways that increase TMAO production. People with type 2 diabetes often have altered gut bacterial composition and reduced kidney function, both of which can raise TMAO. As with cardiovascular disease, it is likely that the relationship is bidirectional to some extent.

Other Associations

Preliminary research has linked TMAO to other conditions including certain cancers, inflammatory bowel disease, and cognitive decline. These associations are generally weaker and less well established than the cardiovascular or kidney findings. They represent active areas of investigation rather than established clinical knowledge. It is important not to over-interpret these early findings or to make health decisions based on them.

Should You Test Your TMAO Levels?

Blood tests for TMAO exist and are available through some commercial laboratories and research settings. Given the research interest and public attention, it is reasonable to wonder whether you should test your TMAO levels. The answer is more nuanced than a simple yes or no.

When TMAO Testing May Be Useful

In research settings, TMAO measurement helps scientists understand dietary responses and disease associations. In clinical practice, TMAO testing is not currently recommended as a routine screening tool by major cardiology organisations such as the American Heart Association or the European Society of Cardiology. It is not yet part of standard cardiovascular risk assessment, which typically includes blood pressure, cholesterol, blood glucose, smoking status, and family history.

Some integrative and functional medicine practitioners offer TMAO testing as part of a broader cardiovascular risk assessment. In these contexts, TMAO may be interpreted alongside other biomarkers to build a more complete picture of an individual's metabolic and cardiovascular health. However, a single TMAO result should not be used to diagnose disease or to make treatment decisions in isolation. TMAO levels can fluctuate based on recent meals—especially fish consumption—so a single measurement may not reflect your habitual levels.

Limitations of TMAO Testing

Several important limitations exist:

• Lack of standardisation: Different laboratories may use different assays and reference ranges, making comparisons difficult.
• Short-term variability: TMAO levels can spike after a single meal, especially fish or red meat. Fasting state and recent dietary history must be considered.
• Unclear clinical thresholds: No universally accepted TMAO target or risk threshold exists.
• No evidence that treating TMAO alone improves outcomes: No large clinical trial has shown that specifically lowering TMAO reduces cardiovascular events, although dietary changes that lower TMAO also tend to lower risk.
• Context dependence: TMAO is influenced by kidney function, liver function, gut microbiome, and diet. Interpretation requires this broader context.

A More Complete Picture Through Microbiome Testing

If you are interested in understanding your TMAO production potential, looking at your gut microbiome may provide complementary information. The presence of bacteria carrying the cutC gene, the overall composition of your microbiome, and your dietary patterns all influence TMA production. A gut microbiome test can provide educational insight into the types of bacteria present and may help you understand your individual metabolic tendencies. It should not replace a medical evaluation or be interpreted as a diagnostic test for heart disease risk.

Anyone concerned about cardiovascular risk should discuss it with a qualified healthcare provider. Standard risk factors—blood pressure, cholesterol, blood glucose, smoking, family history, and lifestyle—remain the foundation of cardiovascular risk assessment. TMAO may eventually become an additional tool in the risk-prediction toolbox, but it is not there yet.

Key Takeaways

• TMAO is a metabolite produced when gut bacteria convert dietary choline, L-carnitine, and betaine into TMA, which the liver then converts into TMAO using the FMO3 enzyme.
• Elevated TMAO has been associated with increased cardiovascular risk in many, but not all, observational studies, and causality is not yet definitively established.
• The gut microbiome—particularly bacteria carrying the cutC gene—plays a central role in TMAO production, and microbiome composition differs between habitual meat-eaters and plant-based eaters.
• Red meat, eggs, fish, and dairy are the main dietary sources of TMAO precursors, but fish raises TMAO without being associated with cardiovascular harm.
• Plant-forward dietary patterns, especially the Mediterranean diet, are consistently linked with lower TMAO levels and better cardiovascular health.
• Reducing red meat, increasing fibre and prebiotic-rich plant foods, and including olive oil may help lower TMAO production naturally.
• TMAO blood tests exist but are not yet standard clinical tools; results require interpretation in the context of diet, kidney function, and overall risk factors.
• Elevated TMAO is also associated with kidney disease and type 2 diabetes, reflecting its role as a broad metabolic marker.
• Individual variability in microbiome composition means that the same diet can produce different TMAO responses in different people.
• A balanced approach—rather than extreme restriction—supports both lower TMAO and overall cardiovascular wellbeing.

Frequently Asked Questions

What is TMAO and why is it important?

TMAO (trimethylamine N-oxide) is a metabolite produced when gut bacteria break down dietary compounds such as choline and L-carnitine into TMA, which the liver then converts to TMAO. It has drawn research attention because elevated blood levels have been associated with increased cardiovascular risk in many studies. However, causality has not been definitively proven, and TMAO is best understood as a biomarker linked to diet, gut microbiome, and metabolic health.

How can I lower TMAO in my body?

Evidence-based strategies include shifting toward a plant-forward diet rich in fibre, vegetables, legumes, whole grains, and nuts; reducing red meat intake; using extra virgin olive oil as a primary fat; and supporting kidney health. Plant-based and vegetarian diets consistently produce the lowest TMAO levels. Regular exercise and maintaining a healthy weight also support lower TMAO production. There is no single "TMAO-lowering" supplement with strong clinical evidence, so food-based approaches remain the most reliable strategy.

2-minute self-check Is a gut microbiome test useful for you? Answer a few quick questions and find out if a microbiome test is actually useful for you. ✔ Takes 2 minutes ✔ Based on your symptoms & lifestyle ✔ Clear yes/no recommendation Check if a test is right for me →

Does TMAO cause heart disease or is it just a marker?

This is one of the central questions in TMAO research. Animal and mechanistic studies suggest TMAO may actively contribute to atherosclerosis, platelet aggregation, and vascular inflammation. Observational human studies consistently link higher TMAO to cardiovascular events. However, no large clinical trial has yet proven that lowering TMAO directly reduces cardiovascular events. Most researchers view TMAO as both a potential contributor and a marker of dietary and metabolic patterns associated with cardiovascular risk.

Are eggs bad for heart health because of TMAO?

Eggs contain choline, a TMAO precursor, and can raise TMAO levels in some people. However, the overall evidence does not support eliminating eggs altogether for most healthy adults. Egg consumption of up to one per day is generally considered acceptable within a heart-healthy diet. People with high cardiovascular risk or specific concerns should discuss egg intake with their healthcare provider, weighing both the choline and cholesterol content against the nutritional benefits of eggs.

Why does fish raise TMAO but is still considered heart-healthy?

Fish naturally contains preformed TMAO and can raise blood TMAO levels directly. Yet large observational studies and clinical trials consistently show that fish consumption is associated with cardiovascular benefit, largely due to omega-3 fatty acids, selenium, vitamin D, and high-quality protein. This apparent paradox suggests that TMAO from fish may behave differently than TMAO produced from gut bacterial conversion, or that the overall nutritional benefits of fish outweigh any TMAO-related risk. Current dietary guidelines still recommend fish 1–2 times per week.

Do vegans and vegetarians have lower TMAO levels?

Yes, generally. Studies have shown that habitual vegans and vegetarians have lower TMAO production after consuming carnitine or choline compared to omnivores. This is partly because their gut microbiomes contain fewer TMA-producing bacteria and partly because their overall dietary intake of TMAO precursors is lower. When vegans are given a carnitine challenge, their TMAO rise is smaller—but not zero—indicating that some TMAO-producing capacity remains even in long-term plant-based eaters.

Can probiotics lower TMAO?

The evidence for probiotics lowering TMAO is currently weak and inconsistent. Most commercial probiotics do not permanently colonise the gut, and their effects on TMAO production have not been reliably demonstrated in human studies. Some strains might theoretically reduce TMA-producing bacteria or support a healthier microbiome, but this remains speculative. A food-first approach that emphasises fibre, fermented foods, and plant diversity is generally preferred over probiotic supplementation for TMAO management, unless a healthcare provider recommends otherwise.

What is DMB and how does it relate to TMAO?

DMB (3,3-dimethyl-1-butanol) is a compound found in extra virgin olive oil and some balsamic vinegars. Research, primarily in animal models, has shown that DMB can inhibit the bacterial enzyme that produces TMA, thereby reducing TMAO levels and attenuating atherosclerosis. Human studies are limited but promising. Including extra virgin olive oil in the diet is already established as heart-healthy for many reasons, and its DMB content may provide an additional benefit by influencing TMAO production.

Is TMAO testing available and should I get tested?

TMAO blood tests are available through some commercial labs, but they are not recommended as routine screening tools by major cardiology organisations. A single TMAO measurement can be misleading because levels fluctuate with recent meals, particularly fish and red meat, and no clinical target has been established. If you are interested in personalised cardiovascular risk assessment, discuss it with your healthcare provider—they can help you interpret TMAO results in the context of your broader risk profile.

How does the keto diet affect TMAO and heart risk?

Very low-carbohydrate, high-fat diets such as keto can vary widely in their composition. Some ketogenic diets are heavy in red meat and saturated fat and low in fibre, which could theoretically increase TMAO production and reduce microbiome diversity. However, not all keto diets are the same—a well-formulated ketogenic diet emphasising fish, olive oil, nuts, and non-starchy vegetables may have very different effects. Long-term effects of ketogenic diets on cardiovascular health are still being studied, and individual results vary. Anyone considering a ketogenic diet should discuss cardiovascular and microbiome considerations with a healthcare professional.

What is the best diet for preventing cardiovascular disease?

The Mediterranean diet is the most extensively studied and recommended dietary pattern for cardiovascular prevention. It emphasises vegetables, fruits, legumes, whole grains, nuts, fish, and olive oil, with limited red meat and processed foods. It supports a healthy gut microbiome and is associated with lower TMAO levels in some studies. Other plant-forward patterns, including vegetarian and DASH-style diets, also support cardiovascular health. The common thread is not a single "superfood" but a dietary pattern that prioritises whole, minimally processed plant foods.

Do cardiologists recommend probiotics?

Cardiologists generally do not specifically recommend probiotics for heart health, though many recognise that a healthy gut microbiome may indirectly support cardiovascular wellbeing. The evidence linking specific probiotic strains to improved cardiovascular outcomes—or lower TMAO—remains limited. Instead, cardiologists typically emphasise dietary patterns rich in fibre and plant foods, regular exercise, and standard risk-factor management. Probiotics may have a role in specific gastrointestinal conditions, but their cardiovascular benefits have not been established.

The Bottom Line: TMAO and Your Health

TMAO is a compelling example of how diet, gut bacteria, liver metabolism, and cardiovascular health intersect. The research has revealed a biologically plausible pathway linking certain dietary patterns—especially those high in red meat and low in plant diversity—to elevated TMAO and, in many studies, to increased cardiovascular risk. What the science has not yet conclusively established is whether TMAO itself is the driving force behind that risk or whether it is primarily a marker of an underlying dietary and metabolic pattern.

For practical purposes, this nuance matters less than the broader conclusion: the dietary patterns that lower TMAO—a plant-forward, fibre-rich, Mediterranean-style diet with moderate fish and limited red meat—also align with what decades of cardiovascular research recommend. Whether TMAO is a causal agent or a marker, the strategies that lower it tend to support heart health for well-established reasons.

Individual variability is significant. Two people consuming the same steak can produce quite different TMAO responses due to differences in their gut microbiome, liver enzyme activity, kidney function, and habitual diet. This is why no single number on a laboratory report can fully capture your cardiovascular risk. A personalised approach that considers your whole diet, lifestyle, medical history, and—for those interested—your microbiome may offer the most meaningful pathway to better health.

Microbiome testing is one way to gain insight into the bacteria that shape how your body processes dietary precursors. It is an educational tool that can contextualise how your gut might be influencing your metabolism, but it is not a substitute for medical evaluation or a clinical diagnosis. If you have concerns about TMAO, heart health, or your gut microbiome, a healthcare provider can help you interpret the evidence and make informed decisions. The emerging science of TMAO is a reminder that the food we eat and the microbes we carry interact in profound and personal ways.

This article is for informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition or before making changes to your health regimen.

Keywords

what is tmao, trimethylamine N-oxide, trimethylamine (TMA), TMAO pathway, gut microbiome, gut bacteria, L-carnitine, choline, phosphatidylcholine, betaine, FMO3 enzyme, cutC gene, red meat, TMAO food sources, TMAO and heart disease, cardiovascular risk, heart attack, stroke, atherosclerosis, vascular inflammation, platelet aggregation, Cleveland Clinic, Dr. Stanley Hazen, DMB (3,3-dimethyl-1-butanol), olive oil, Mediterranean diet, plant-based diet, vegetarian diet, vegan diet, fibre, prebiotics, probiotics, how to lower tmao, lower TMAO naturally, TMAO test, trimethylamine n-oxide metabolism, animal products and heart risk, kidney disease, type 2 diabetes, metabolic health, personalized microbiome analysis